logo

For the Inventor, By the Inventor

Porton, United Kingdom

Robin Michael Black

This inventor holds 10 USPTO granted patents. Top assignee: John Wyeth Brother, Limited. Active years: 1976-1978.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robin Michael Black. Retrieved from https://idiyas.com/inventor/robin-michael-black

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10

% Patents Active = 100.0

Average Co-Inventor Count = 1.6

ph-index = 2

Forward Citations = 19(Granted Patents)


Location History:

  • Iver Heath, E (1976)
  • Porton, EN (1976 - 1978)

Company Filing History:

goldMedal10 out of 299 
 
John Wyeth Brother, Limited
 patents

Years Active: 1976-1978

Loading Chart...
10 patents (USPTO):Explore Patents
1. 4073906 - Pyrimido 1,2-b!isoquinolines (1978-02-14),
2. 4061754 - Imidazo[1,2-a]quinolines (1977-12-06),
3. 4056529 - Dibenzopyrimidoazepines (1977-11-01),
4. 4048177 - Certain 2-substituted 4-phenylquinoline-4-ols (1977-09-13),
5. 3998842 - Diazepino[1,2-.alpha.]indoles (1976-12-21),
6. 3996207 - Derivatives of tetrahydro-1H-1,3-diazepine and hexahydro-1,3-diazocine (1976-12-07),
7. 3989709 - Fused ring benzimidazole derivatives (1976-11-02),
8. 3971782 - Fluorene derivatives (1976-07-27),
9. 3969528 - Hexahydroimidazo[1,5-A]pyridines (1976-07-13),
10. 3965112 - Imidazoline derivatives (1976-06-22),

Title: The Innovative Contributions of Robin Michael Black

Introduction

Robin Michael Black is a distinguished inventor based in Porton, GB. He has made significant contributions to the field of pharmaceuticals, holding a total of nine patents. His work primarily focuses on the development of compounds with therapeutic applications.

Latest Patents

Among his latest patents are the pyrimido 1,2-b!isoquinolines, which relate to compounds that have utility as anti-gastric ulcer agents. These compounds are characterized by a specific formula where R.sup.1 and R.sup.2 can represent various chemical groups, including hydrogen and lower alkyl. Another notable patent is for imidazo[1,2-a]quinolines, which possess hypotensive activity. This invention also includes a detailed formula that outlines the various substituents that can be present in the compounds.

Career Highlights

Robin Michael Black is currently associated with John Wyeth & Brother Limited, where he continues to innovate and develop new pharmaceutical compounds. His extensive experience in the field has led to the creation of several important patents that contribute to medical science.

Collaborations

He has collaborated with notable coworkers, including Alan C White and John Leheup Archibald, to advance research and development in his field.

Conclusion

Robin Michael Black's contributions to pharmaceutical innovations are noteworthy, and his patents reflect his commitment to improving health outcomes through scientific advancements. His work continues to influence the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…